Loading your page…
Each register with its number of medicines and a few of them.
Health Canada · 1 medicine
AEMPS · 1 medicine
AIFA · 1 medicine
CBG-MEB · 1 medicine
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
PHARMAC · 1 medicine
FDA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
6 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Matulane | United States | 50MG BASE | capsule | Marketed | Leadiant Biosci INC |
| Natulan 50 MG Cápulas Duras | Spain | 50 mg | cápsula dura | Marketed | Leadiant Biosciences Ireland Limited |
| Natulan | Italy | Capsula rigida | Authorised | Leadiant GMBH | |
| Natulan, capsules, hard 50 mg | Netherlands | Capsule, hard | Authorised | Leadiant Biosciences Ireland Limited | |
| Matulane | Canada | 50 MG | Capsule | Marketed | Leadiant Biosciences, INC |
| Natulan | New Zealand | Cap 50 mg | Funded |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, CBG-MEB, FDA, Health Canada and PHARMAC. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
